| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/12/2002 | US20020127239 LipL32 polypeptide is useful for inducing an immune response to a pathogenic spirochete in a patient |
| 09/12/2002 | US20020127238 Utilizing a modified HIV-1 envelope protein or fragment or DNA encoding a modified HIV-1 envelope protein or fragment, wherein modified protein having a HIV-1 envelope protein V2 region deletion |
| 09/12/2002 | US20020127237 Contacting sample with preferntial nucleic acid molecule in which the nucleic acid will selectively hydbridize to a prostate specific nucleic acid, detecting hybridization of nucleic acid molecule to prostate specific nucleic acid |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127231 Extracellular domains of a heterodimeric protein operatively linked to immunoglobulin heavy and light chain polypeptides |
| 09/12/2002 | US20020127227 Antagonist monoclonal antibodies (mAb) that bind to the RHAMM (receptor for hyaluronic acid mediated motility) receptor; useful for preventing proliferative disease states in a mammal |
| 09/12/2002 | US20020127225 Nucleic acid and amino acid sequences of an annexin binding protein useful in diagnosis, prevention, treatment of cancer, immune disorder and neurological disorders |
| 09/12/2002 | US20020127222 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 09/12/2002 | US20020127221 Urocortin proteins and uses thereof |
| 09/12/2002 | US20020127218 Phytase variants |
| 09/12/2002 | US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide) |
| 09/12/2002 | US20020127210 Transplants for myocardial scars |
| 09/12/2002 | US20020127209 Tripeptide of intracellular tyrosine-based activation motifs (ITAM) mediates trafficking of targets phagocytosed via Fc gamma RIIA to the lysosomal compartment |
| 09/12/2002 | US20020127205 Immunoregulatory molecule expressed by the cell(s) are capable of inhibiting T cell activation and/or natural killer cell-mediated immune response against the cell upon transplantation into a recipient subject |
| 09/12/2002 | US20020127204 Improvements in or relating to protection against intracellular infection |
| 09/12/2002 | US20020125136 Spectral calibration of fluorescent polynucleotide separation apparatus |
| 09/12/2002 | DE10111676A1 Erhöhung des Vitamin-E-Gehalts in Organismen durch Erhöhung der Tyrosinaminotransferase-Aktivität Increasing the vitamin E content in organisms by increasing the tyrosine aminotransferase activity |
| 09/12/2002 | DE10110350A1 New nucleic acid encoding part of a mitogenic protein kinase, useful for treating e.g. acquired immune deficiency syndrome and for drug screening, also related peptide |
| 09/12/2002 | DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene |
| 09/12/2002 | DE10109466A1 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 09/12/2002 | DE10109166A1 Avilamycin-Derivate Avilamycin derivatives |
| 09/12/2002 | DE10107317A1 Methode zur Detektion von Mutationen Method for the detection of mutations |
| 09/12/2002 | DE10063387A1 New elongase gene extends 16, 18 and 20 carbon fatty acids, useful to manipulate plants to produce polyunsaturated fatty acids for the foodstuffs, cosmetics and pharmaceutical industries |
| 09/12/2002 | CA2853831A1 Method for rapid detection and identification of bioagents |
| 09/12/2002 | CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2441476A1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | CA2440513A1 Nucleic acids for transforming fish cells and methods for their use |
| 09/12/2002 | CA2440358A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 09/12/2002 | CA2440235A1 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 09/12/2002 | CA2440092A1 Protein c variants |
| 09/12/2002 | CA2440044A1 Cloning vectors and method for molecular cloning |
| 09/12/2002 | CA2440035A1 A system and method for managing gene expression data |
| 09/12/2002 | CA2439986A1 Cell visual characteristic-modifying sequences |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439934A1 Use of protein histidine phosphatase |
| 09/12/2002 | CA2439929A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | CA2439926A1 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/12/2002 | CA2439899A1 Improved skin substitutes and uses thereof |
| 09/12/2002 | CA2439854A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 09/12/2002 | CA2439852A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | CA2439843A1 Compositions and methods for increasing amino acid absorption in mammals |
| 09/12/2002 | CA2439795A1 Method for the amplification and detection of dna using a transcription based amplification |
| 09/12/2002 | CA2439779A1 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 09/12/2002 | CA2439684A1 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene |
| 09/12/2002 | CA2439682A1 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 09/12/2002 | CA2439681A1 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell |
| 09/12/2002 | CA2439655A1 Method for rapid detection and identification of bioagents |
| 09/12/2002 | CA2439636A1 Mouse cytokine receptor |
| 09/12/2002 | CA2439628A1 Vaccine |
| 09/12/2002 | CA2439625A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | CA2439620A1 Viral reporter particles |
| 09/12/2002 | CA2439607A1 The guinea pig proteinase-activated receptor 4 and its activating peptide |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439531A1 A method of detecting nucleic acid molecules |
| 09/12/2002 | CA2439504A1 Compositions and methods relating to osteoarthritis |
| 09/12/2002 | CA2439456A1 Novel abcg4 transporter and uses thereof |
| 09/12/2002 | CA2439402A1 Pcr method |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439176A1 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv |
| 09/12/2002 | CA2439042A1 Use of fusion proteins whose n-terminal part is a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 09/12/2002 | CA2438505A1 Altered peptide ligands |
| 09/12/2002 | CA2438375A1 Plant cell having animal-type sugar chain adding function |
| 09/12/2002 | CA2437398A1 Molecules for disease detection and treatment |
| 09/12/2002 | CA2436815A1 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins |
| 09/12/2002 | CA2435277A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | CA2434601A1 Methods for specifically inhibiting histone deacetylase-4 |
| 09/12/2002 | CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | CA2428798A1 Fen-1 endonucleases from archaeoglobus veneficus |
| 09/12/2002 | CA2427113A1 Novel human 7tm proteins and polynucleotides encoding the same |
| 09/11/2002 | EP1239286A2 Biochemical sensors, methods for their manufacture and biochemical methods and systems for testing substances of interest |
| 09/11/2002 | EP1239050A1 Method of testing remedy or preventive for hyperlipemia |
| 09/11/2002 | EP1239047A2 Method for producing proteins |
| 09/11/2002 | EP1239044A1 Production of genetically modified plants with puroindolines |
| 09/11/2002 | EP1239043A2 Fusion proteins comprising tumour necrosis factor receptor |
| 09/11/2002 | EP1239042A1 Transposase and method of gene modification |
| 09/11/2002 | EP1239041A2 Method for producing L-amino acid using bacteria belonging to the genus Escherichia |
| 09/11/2002 | EP1239040A2 Mutations in the rpoB gene of L-lysine producing Corynebacterium glutamicum strains and process for the preparation of L-lysine |
| 09/11/2002 | EP1239039A1 Novel polypeptide and dna thereof |
| 09/11/2002 | EP1239038A1 High-throughput identification of modulators of e2f activity |
| 09/11/2002 | EP1239037A1 PROCESS FOR PRODUCING KiSS-1 PEPTIDE |
| 09/11/2002 | EP1239036A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 09/11/2002 | EP1239035A1 Novel protein and gene |
| 09/11/2002 | EP1239034A2 Large circular target-specific antisense nucleic acids |
| 09/11/2002 | EP1239033A1 Semaphorin receptor |
| 09/11/2002 | EP1239032A1 Lactic acid bacteria as agents for treating and preventing allergy |
| 09/11/2002 | EP1238986A2 Use of Vascular endothelial cell growth factor antagonists |
| 09/11/2002 | EP1238985A1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 09/11/2002 | EP1238982A1 A Fluorescent Protein |
| 09/11/2002 | EP1238584A1 Method for producing livestock individuals from cells of established cell line |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |